However, in obesity, leptin resistance, marked by elevated circulating leptin but impaired BBB transport and receptor desensitization, blunts this neuroprotective axis, accelerating both amyloid and tau pathology. Here, MAPT is linked to obesity due to melanocortin 4 receptor deficiency.